Get Your Free Echinacea Research Guide

Understanding Echinacea: What the Research Shows

Echinacea is a flowering plant native to North America that has been used in traditional medicine for hundreds of years. The plant grows in prairies and open woods across the central and eastern United States. Three main species are used in research and commercial products: Echinacea purpurea, Echinacea angustifolia, and Echinacea pallida. Each species contains different active compounds, which is why research results can vary depending on which type was studied.

Get Your Free Roomba Wi-Fi Connection Guide →

The National Center for Complementary and Integrative Health (NCCIH), which is part of the National Institutes of Health, has funded numerous studies on echinacea. According to their research summaries, scientists have investigated whether echinacea can reduce the duration of colds, prevent colds from occurring, or reduce symptom severity. The compounds in echinacea that researchers focus on include polysaccharides, alkamides, and caffeic acid derivatives. These compounds are thought to interact with the immune system, though exactly how they work is still being studied.

A major study published in the journal Lancet Infectious Diseases in 2012 examined whether echinacea could prevent upper respiratory infections in people exposed to cold viruses. Researchers found that people who took echinacea had slightly shorter infections compared to those who took a placebo, but the difference was small—about one day shorter on average. Other studies have shown mixed results, with some suggesting echinacea may reduce cold symptoms by a small amount if taken early in illness, while others found no significant difference.

The amount of echinacea used in studies varies widely, from 300 milligrams to 2,500 milligrams daily, and study lengths range from a few weeks to several months. This variation in research methods makes it difficult to draw firm conclusions. One study from the University of Wisconsin that followed 719 people found that echinacea did not reduce cold duration in children, though some studies in adults showed modest benefits. The research guide you can obtain will explain these different findings and what they mean for understanding echinacea's actual effects.

Takeaway: Research on echinacea shows mixed results, with most studies indicating small or minimal effects on cold duration or prevention. Understanding what actual studies found—rather than marketing claims—helps you make informed decisions about whether echinacea might be worth trying.

How Different Forms of Echinacea Are Studied

Echinacea comes in many different forms, and the type used in research affects what scientists can conclude. The most common forms include dried herb capsules, liquid extracts, teas, and tinctures. Each form has different concentrations of active compounds. For example, a standardized extract in capsule form may contain a guaranteed percentage of certain compounds, while a tea made from dried leaves may have varying amounts depending on brewing time and water temperature.

Get Your Free Chase Bank Account Information Guide →

Most rigorous clinical trials use standardized extracts where the dose and active compound content are controlled. This allows researchers to know exactly what participants are receiving. The Echinacea Prevention Study, a large trial that tracked 1,395 participants over four months, used a standardized extract that provided 2.4 milligrams of alkamides per dose. Participants either received the echinacea extract or a matching placebo pill. This type of controlled study provides the most reliable information about whether echinacea actually works.

Whole herb products, by contrast, can vary significantly in their composition. One batch of echinacea tea might contain different amounts of active compounds than another batch from the same company, depending on when the plants were harvested, how they were dried, and how they were processed. This variability makes it harder for researchers to draw conclusions and also makes it harder for consumers to know what they're actually getting. Some commercial products labeled as echinacea contain very little of the plant or contain multiple ingredients, making it unclear which component might have any effect.

The route of administration—whether taken by mouth as a capsule, consumed as a tea, or used as a tincture—can also affect how much of the active compounds reach the body. A 2016 analysis in the journal Phytotherapy Research reviewed studies using different echinacea preparations and found that results were more consistent when standardized extracts were used compared to whole herb preparations. The research guide explains how these different forms were used in studies and why this matters for interpreting results.

Takeaway: Standardized extract forms produce more reliable research results than whole herb products because the active compound content is controlled and known. When considering echinacea products, looking for standardized extracts with labeled active compound amounts gives you better information about what you're purchasing.

Research Findings on Cold Prevention and Duration

One of the most common claims about echinacea is that it can prevent colds. The research on prevention shows complicated results. Some studies found that people who took echinacea regularly had fewer colds over a winter season, while other studies found no difference. A meta-analysis published in the Journal of the American Medical Association in 2000 reviewed 16 different echinacea studies and found that echinacea reduced the risk of developing a cold by only about 10 to 15 percent. This means that if 100 people took echinacea, about 10 to 15 fewer might catch a cold compared to 100 people taking a placebo, assuming they had similar exposure to cold viruses.

Learn About Senior ID Programs Available →

More recent research has been less encouraging about prevention. The Echinacea Prevention Study, published in 2010, involved 719 healthy adults who took either echinacea or placebo for four months during cold season. Researchers found no difference in how many people caught colds between the two groups. About 24 percent of people in the echinacea group caught a cold, compared to 25 percent in the placebo group—a difference that could easily occur by chance.

For reducing the duration of colds once someone is already sick, the findings are slightly more promising. Several studies have examined whether taking echinacea when cold symptoms first appear can shorten how long the illness lasts. A 2014 systematic review in the Cochrane Database examined 24 different studies on this question. Overall, the review found that echinacea might reduce cold duration by about 1 to 2 days if taken early in illness. However, the review also noted that the quality of evidence was moderate, meaning more rigorous studies are needed to be confident in this finding.

The Lancet Infectious Diseases study mentioned earlier found that among people who were exposed to cold viruses in a controlled laboratory setting, those who took echinacea experienced symptoms that lasted about 1.3 days shorter than those who took placebo. While this represents a real reduction in symptom duration, it is a relatively small difference. Whether a one-day reduction in cold duration matters to any particular person is a personal decision that depends on how much they value the benefit versus the cost and any side effects.

Takeaway: Research suggests echinacea may slightly reduce cold duration if taken early in illness—roughly one day shorter—but has little to no effect on preventing colds from occurring. This modest benefit should be weighed against costs and individual circumstances.

What Research Says About Safety and Side Effects

In clinical research studies, echinacea has generally been well tolerated with mild side effects. The most commonly reported side effects are gastrointestinal complaints, including nausea, stomach upset, and diarrhea. These side effects typically occur in only a small percentage of people taking echinacea and are usually mild. In the large prevention study of 719 adults, there was no significant difference in reported side effects between the echinacea group and the placebo group.

Learn About Vertigo Causes and Relief Options →

Some people experience allergic reactions to echinacea, particularly those who are allergic to plants in the daisy family, which includes echinacea, ragweed, chrysanthemums, and marigolds. Allergic reactions can range from mild skin reactions to more serious responses. People with known allergies to plants in the daisy family should avoid echinacea products. Additionally, some studies have noted that echinacea may stimulate the immune system, which could theoretically be problematic for people with autoimmune conditions, though research specifically examining this in autoimmune patients is limited.

The safety profile in children is less well studied than in adults. A notable study published in Pediatrics in 2003 examined echinacea use in 524 children with upper respiratory